Company Name: Merus N.V.      

Merus B.V. is a clinical stage immuno-oncology company. The company is engaged in the development of bispecific antibody therapeutics. The company’s developmental pipeline includes treatments for solid and hematological tumors.

Ticker Symbol: MRUS (NASDAQ)

Company Website: www.merus.nl

Social Media: Merus LinkedIn Page

Headquarters: Utrecht, the Netherlands